Deutsche Bank sees improving risk/reward for Valeant shares
In a research note titled "Still warming up," Deutsche Bank analyst Gregg Gilbert applauds the new management team at Valeant Pharmaceuticals for managing near-term debt...
Author : The Fly
Cisco price target raised to $40 from $36 at Citi
Citi analyst Jim Suva raised his price target for Cisco Systems to $40 saying the company last night reported "solid" results with a "much better...
Piper ups Cisco target to $37 on ‘strong’ quarter
Cisco Systems reported modest upside versus October quarter estimates while guiding revenue and earnings above expectations for the January quarter, Piper Jaffray analyst Troy Jensen...
On The Fly: Top stock stories for Wednesday
Stocks opened sharply lower and remained in the red throughout the session, though the major averages improved from their worst levels early in the day....
On The Fly: What to watch for in NetApp’s earnings report
NetApp (NTAP) is scheduled to report results of its fiscal second quarter after the market close on Wednesday, November 15, with a conference call scheduled...
Food makers slide as Amazon drops prices again at Whole Foods
Shares of several packaged food makers are sliding after Amazon (AMZN) announced new lower prices on additional grocery items at Whole Food stores. General Mills...
As Amazon threat to Netflix may lessen, Apple viewed as possible new competitor
Amazon (AMZN) has scrapped plans to launch an online streaming service bundling broadcast and cable networks, according to media reports, with The Verge saying that...
CDK Global rises after report of exploring potentail sale
Shares of CDK Global (CDK) are rising in early trading after Dealreporter said, according to contacts, that the company is working with bankers at Morgan...
Airbus, Indigo sign agreement for 430 plans worth $49.5B at list
Airbus and Indigo Partners' four portfolio airlines signed a Memorandum of Understanding for the purchase by the four airlines of 430 additional A320neo Family aircraft....
Loxo takeover by Bayer not off the table, says Citi
Bayer's (BAYRY) precedent for collaborations preceding acquisitions, as in the Algeta deal, implies an acquisition of Loxo Oncology (LOXO) is not off the table following...